Journal article · 2025 · Open access

Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial

Jiancheng Ye, Lisa R. Hirschhorn, Abigail S. Baldridge, Erica Jamro-Comer, Ikechukwu A. Orji, Gabriel Lamkur Shedul, Nanna R. Ripiye, Tunde Massey-Ferguson Ojo, Helen Eze, Grace Julcit Shedul, Eugenia N. Ugwuneji, Rosemary Okoli and 7 more

Implementation Science, 21(1), 1 · Published 26 November 2025 · DOI 10.1186/s13012-025-01472-1

Open full textCite this paper

In brief

“Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial” is a 2025 journal article by Jiancheng Ye and 18 co-authors, published in Implementation Science. OpenAlex counts 11 citations as of 17 November 2026, which puts it in the top 5% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Implementation Science.

Citations
11
Most cited in
2026 (8)
Field-weighted impact
6.74
References
49
Authors
19

Abstract

BACKGROUND: The Hypertension Treatment in Nigeria Program was implemented across 60 primary healthcare centers (PHCs) in Nigeria to improve hypertension treatment and control using the World Health Organization's HEARTS package. This study reports the program's implementation outcomes. METHODS: The Hypertension Treatment in Nigeria Program used a type 2 hybrid interrupted time series design, and data were collected from January 2020 to December 2023. The RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework guided the evaluation, focusing on key metrics such as patients' and clinics' characteristics, prescription rate of fixed dose combination (FDC) drugs, medication availability, and retention. RESULTS: Among 21,922 patients recruited (mean [SD] age = 49 [12], 68.1% female) from 60 primary healthcare centers (78.3% rural). Prescription of FDC increased from 16.3 (95% CI: 4.8%-27.8%) to 65.2% (95% CI: 64.0%-66.3%). The program distributed 336,116 30-day medication supplies, and nearly all (95%) PHCs had at least one 30-day supply of any BP-lowering medication in stock after the drug revolving fund implemented. The patient retention rate at 6 months increased between the pre-implementation to implementation periods from 59.9% to 63.1%. CONCLUSIONS: The Hypertension Treatment in Nigeria Program successfully integrated hypertension services into Nigerian primary healthcare centers. Future efforts should focus on sustaining and scaling up the program's success. TRIAL REGISTRATION: The trial has been registered at www. CLINICALTRIALS: gov under NCT04158154.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ye, J., Hirschhorn, L. R., Baldridge, A. S., Jamro-Comer, E., Orji, I. A., Shedul, G. L., Ripiye, N. R., Ojo, T. M.-F., Eze, H., Shedul, G. J., Ugwuneji, E. N., Okoli, R., Ale, B. M., Osagie, S., Sanuade, O. A., Iyer, G. Y. N., Kandula, N. R., Ojji, D. B., & Huffman, M. D. (2025). Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial. Implementation Science, 21(1), 1. https://doi.org/10.1186/s13012-025-01472-1

MLA 9

Ye, Jiancheng, et al. “Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial.” Implementation Science, vol. 21, no. 1, 2025, p. 1. https://doi.org/10.1186/s13012-025-01472-1.

Chicago

Ye, Jiancheng, Lisa R. Hirschhorn, Abigail S. Baldridge, Erica Jamro-Comer, Ikechukwu A. Orji, Gabriel Lamkur Shedul, Nanna R. Ripiye, et al. 2025. “Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial.” Implementation Science 21 (1): 1. https://doi.org/10.1186/s13012-025-01472-1.

Harvard

Ye, J. et al. (2025) ‘Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial’, Implementation Science, 21(1), p. 1. doi:10.1186/s13012-025-01472-1.

IEEE

J. Ye et al., “Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial,” Implementation Science, vol. 21, no. 1, p. 1, 2025, doi: 10.1186/s13012-025-01472-1.

BibTeX

@article{ye2025implementation,
  title     = {{Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial}},
  author    = {Ye, Jiancheng and Hirschhorn, Lisa R. and Baldridge, Abigail S. and Jamro-Comer, Erica and Orji, Ikechukwu A. and Shedul, Gabriel Lamkur and Ripiye, Nanna R. and Ojo, Tunde Massey-Ferguson and Eze, Helen and Shedul, Grace Julcit and Ugwuneji, Eugenia N. and Okoli, Rosemary and Ale, Boni Maxime and Osagie, Samuel and Sanuade, Olutobi Adekunle and Iyer, G. Y. N. and Kandula, Namratha R. and Ojji, Dike Bevis and Huffman, Mark D.},
  journal   = {Implementation Science},
  year      = {2025},
  volume    = {21},
  number    = {1},
  pages     = {1},
  doi       = {10.1186/s13012-025-01472-1},
  url       = {https://doi.org/10.1186/s13012-025-01472-1}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science

  • antihypertensive therapy
  • primary health centers
  • fixed-dose combination antihypertensive drugs
  • drug availability
  • patient retention
  • RE-AIM framework
  • hypertension control
  • Nigeria

Work with this paper

Most-cited papers in Health Professions

All highly cited Health Professions papers

Questions about this paper

How do I cite this paper in APA style?

Ye, J., Hirschhorn, L. R., Baldridge, A. S., Jamro-Comer, E., Orji, I. A., Shedul, G. L., Ripiye, N. R., Ojo, T. M.-F., Eze, H., Shedul, G. J., Ugwuneji, E. N., Okoli, R., Ale, B. M., Osagie, S., Sanuade, O. A., Iyer, G. Y. N., Kandula, N. R., Ojji, D. B., & Huffman, M. D. (2025). Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial. Implementation Science, 21(1), 1. https://doi.org/10.1186/s13012-025-01472-1

How many times has this paper been cited?

11 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Implementation Science: sign in and open the full text from this page.

Who wrote this paper?

Jiancheng Ye, Lisa R. Hirschhorn, Abigail S. Baldridge, Erica Jamro-Comer, Ikechukwu A. Orji, Gabriel Lamkur Shedul, Nanna R. Ripiye, Tunde Massey-Ferguson Ojo, Helen Eze, Grace Julcit Shedul, Eugenia N. Ugwuneji, Rosemary Okoli and 7 more.

What is the DOI of this paper?

10.1186/s13012-025-01472-1, permanently at https://doi.org/10.1186/s13012-025-01472-1. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.